<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="149754">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02018588</url>
  </required_header>
  <id_info>
    <org_study_id>0019850580T</org_study_id>
    <nct_id>NCT02018588</nct_id>
  </id_info>
  <brief_title>Tryptophan Requirement of Healthy School Age Children</brief_title>
  <official_title>Tryptophan Requirement of Healthy School Age Children Determined by the Indicator Amino Acid Oxidation Method</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Hospital for Sick Children</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Hospital for Sick Children</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our objective is to determine the requirement for the amino acid tryptophan in school age
      children using the indicator amino acid technique.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Bio-availability Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Requirement of tryptophan in school age children</measure>
    <time_frame>4 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>By collection of stable isotope labeled CO2 from the indicator amino acid phenylalanine in response to different intake levels of tryptophan we will be able to determine tryptophan requirements.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">7</enrollment>
  <condition>Amino Acid Requirements in Healthy Children</condition>
  <arm_group>
    <arm_group_label>tryptophan intake</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Graded levels of tryptophan will be given to each subject on different study days around the anticipated breakpoint.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>tryptophan</intervention_name>
    <description>graded levels of tryptophan will be given to each subject</description>
    <arm_group_label>tryptophan intake</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy children age 6-10 inclusive

        Exclusion Criteria:

          -  significant recent illness
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Paul B Pencharz, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Hospital for Sick Children, Toronto, Canada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Abeer Almokbel</last_name>
    <phone>4168137454</phone>
    <email>abeer.al-mokbel@sickkids.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>The Hospital for Sick Children</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5G1X8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Tomlinson, MBChB, PhD</last_name>
      <phone>4168137654</phone>
      <phone_ext>302474</phone_ext>
      <email>christopher.tomlinson@sickkids.ca</email>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 17, 2013</lastchanged_date>
  <firstreceived_date>December 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Hospital for Sick Children</investigator_affiliation>
    <investigator_full_name>Dr. Paul Pencharz</investigator_full_name>
    <investigator_title>Professor of Paediatrics and Nutritional Sciences (Emeritus) University of Toronto, Senior Scientist Research Institute, The Hospital for Sick Children</investigator_title>
  </responsible_party>
  <keyword>requirements</keyword>
  <keyword>amino acid</keyword>
  <keyword>tryptophan</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Tryptophan</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
